




Searching News Database: Evoke
HSMN NewsFeed - 9 Jun 2020
Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer
Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer
HSMN NewsFeed - 28 Jun 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group
HSMN NewsFeed - 6 Jul 2016
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
HSMN NewsFeed - 26 Feb 2009
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
Inspire Medical Systems Completes First Implant of the Inspire II System to Treat Obstructive Sleep Apnea
HSMN NewsFeed - 31 Mar 2008
IMPAX Establishes Branded Products Division with Appointments of Senior Management
IMPAX Establishes Branded Products Division with Appointments of Senior Management
HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
HSMN NewsFeed - 30 Jan 2008
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
HSMN NewsFeed - 29 May 2007
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
HSMN NewsFeed - 17 Jan 2007
Conor Medsystems Comments on Netherlands Court Decision on Angiotech Patent
Conor Medsystems Comments on Netherlands Court Decision on Angiotech Patent
Additional items found! 12

Members Archive contains
12 additional stories matching:
Evoke
(Password required)
Evoke
(Password required)